|
|
| Research article summary (published 30 May 2007): |
A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate.
Full Abstract
Numerous lines of evidence have highlighted the involvement of the dopamine system in the pathophysiology of schizophrenia. Association studies of dopaminergic genes such as the dopamine D2 receptor gene (DRD2), however, have produced contradictory results. To test the hypothesis that DRD2 polymorphisms are associated with schizophrenia, we investigated two DRD2-related polymorphisms (TaqI A1/A2 or rs1800497 and -141-C Ins/Del or rs1799732) in a Spanish population isolate from northern Spain consisting of 165 controls and 119 patients with schizophrenia. The TaqI A1 allele was less frequent in schizophrenic patients than in controls (P=0.002). A similar association was found for the TaqI A2/A2 genotype (P=0.0003). No association was found for the DRD2 -141-C Ins/Del polymorphism. The strong association between a potentially functional polymorphism, downstream of the DRD2 gene and schizophrenia, suggests that the direct or indirect functional effects of this polymorphism, acting on either the ANKK1 or DRD2 genes, may play a role in the pathophysiology of schizophrenia.
Learn Faster Today Improve your study skills
Author information
Author/s: Parsons, Michael J (MJ); Mata, Ignacio (I); Beperet, Maria (M); Iribarren-Iriso, Fernando (F); Arroyo, Barbara (B); Sainz, Ricardo (R); Arranz, Maria J (MJ); Kerwin, Robert (R);
Affiliation: Clinical Neuropharmacology, Institute of Psychiatry, KCL, London, UK. m.parsons(-atsign-)iop.kcl.ac.uk
Journal and publication information
Publication Type: Journal Article
Journal: Psychiatric genetics (Psychiatr Genet), published in England. (Language: eng)
Reference: 2007-Jun; vol 17 (issue 3) : pp 159-63
Dates: Created 2007/04/09; Completed 2007/08/06;
PMID: 17417059, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients.
13 May 2008 - A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part I.
29 Apr 2008 - Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
30 Apr 2008 - -141C Ins/Del polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in a Spanish population.
30 May 2008 - Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese.
28 Apr 2008 - Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population.
31 May 2008 - The value of interleukin-12B (p40) gene promoter polymorphism in patients with schizophrenia in a region of East Turkey.
30 May 2008 - No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.
27 May 2008 - Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia.
16 Jul 2008 - Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder.
30 May 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.